DD107208A1 - - Google Patents

Info

Publication number
DD107208A1
DD107208A1 DD171405A DD17140573A DD107208A1 DD 107208 A1 DD107208 A1 DD 107208A1 DD 171405 A DD171405 A DD 171405A DD 17140573 A DD17140573 A DD 17140573A DD 107208 A1 DD107208 A1 DD 107208A1
Authority
DD
German Democratic Republic
Application number
DD171405A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to DD171405A priority Critical patent/DD107208A1/xx
Publication of DD107208A1 publication Critical patent/DD107208A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
DD171405A 1973-06-04 1973-06-04 DD107208A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DD171405A DD107208A1 (fr) 1973-06-04 1973-06-04

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD171405A DD107208A1 (fr) 1973-06-04 1973-06-04

Publications (1)

Publication Number Publication Date
DD107208A1 true DD107208A1 (fr) 1974-07-20

Family

ID=5491561

Family Applications (1)

Application Number Title Priority Date Filing Date
DD171405A DD107208A1 (fr) 1973-06-04 1973-06-04

Country Status (1)

Country Link
DD (1) DD107208A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100157A2 (fr) * 1982-07-02 1984-02-08 E.R. Squibb & Sons, Inc. Formulation d'une pastille à nystatine
DE10125731A1 (de) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Darreichungsform von immunologischen Wirkstoffen
WO2004075875A1 (fr) 2003-02-28 2004-09-10 Alk-Abello A/S Forme de dosage presentant une matrice en saccharide
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
EP2436395A2 (fr) 2002-11-26 2012-04-04 Alk-Abelló A/S Forme pharmaceutique allergène
EP2563316A1 (fr) * 2010-04-30 2013-03-06 Allovate, LLC Procédés, articles et trousses pour la désensibilisation allergique par l'intermédiaire des muqueuses orales

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100157A3 (en) * 1982-07-02 1984-10-17 E.R. Squibb & Sons, Inc. Nystatin pastille formulation
EP0100157A2 (fr) * 1982-07-02 1984-02-08 E.R. Squibb & Sons, Inc. Formulation d'une pastille à nystatine
DE10125731A1 (de) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Darreichungsform von immunologischen Wirkstoffen
US9408805B2 (en) 2002-11-26 2016-08-09 Alk-Abello A/S Allergen dosage form
US10471008B2 (en) 2002-11-26 2019-11-12 Alk-Abelló A/S Allergen dosage form
EP2436395A2 (fr) 2002-11-26 2012-04-04 Alk-Abelló A/S Forme pharmaceutique allergène
EP2436395A3 (fr) * 2002-11-26 2012-06-20 Alk-Abelló A/S Forme pharmaceutique allergène
US8329196B2 (en) 2002-11-26 2012-12-11 Alk-Abello A/S Allergen dosage form
US10080719B2 (en) 2002-11-26 2018-09-25 Alk-Abelló A/S Allergen dosage form
US9415015B2 (en) 2002-11-26 2016-08-16 Alk-Abello A/S Allergen dosage form
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
WO2004075875A1 (fr) 2003-02-28 2004-09-10 Alk-Abello A/S Forme de dosage presentant une matrice en saccharide
EP2563316A4 (fr) * 2010-04-30 2014-06-11 Allovate Llc Procédés, articles et trousses pour la désensibilisation allergique par l'intermédiaire des muqueuses orales
EP2563316A1 (fr) * 2010-04-30 2013-03-06 Allovate, LLC Procédés, articles et trousses pour la désensibilisation allergique par l'intermédiaire des muqueuses orales
EP3524259A1 (fr) * 2010-04-30 2019-08-14 Allovate, LLC Procédés, articles et kits de désensibilisation allergique par l'intermédiaire de la muqueuse orale
EP4011362A1 (fr) * 2010-04-30 2022-06-15 Allovate, LLC Procédés, articles et kits de désensibilisation allergique par l'intermédiaire de la muqueuse orale

Similar Documents

Publication Publication Date Title
AU476761B2 (fr)
AU465372B2 (fr)
AU495860B2 (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU471343B2 (fr)
AU465453B2 (fr)
AU465434B2 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
AU466283B2 (fr)
AU476696B2 (fr)
AU472848B2 (fr)
AU477823B2 (fr)
AU477824B2 (fr)
AR193950A1 (fr)
AU471461B2 (fr)
AU447540B2 (fr)
AU461342B2 (fr)
AU476873B1 (fr)
AU1891376A (fr)
CH566408A5 (fr)
CH559036A5 (fr)
AU479420A (fr)